Immunic, Inc. SEC filings IMUX
Immunic, Inc. has 832 filings in SEC EDGAR's recent list, going back to Feb 18, 2004. Its latest annual report, Form 10-K, was filed on Feb 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Nov 5, 2026 | Nov 5, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 2, 2026 | — |
| S-8 | Employee stock plan registration | Oct 1, 2026 | — |
| 4 | Insider transaction | Sep 18, 2026 | Sep 16, 2026 |
| 4 | Insider transaction | Sep 18, 2026 | Sep 16, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 11, 2026 | Sep 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2026 | Sep 9, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| S-8 | Employee stock plan registration | Aug 12, 2026 | — |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Aug 11, 2026 | Aug 6, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Aug 10, 2026 | Aug 6, 2026 |
| 3 | Initial insider ownership | Aug 10, 2026 | Aug 6, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 6, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 4, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 16, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 14, 2026 | Jul 14, 2026 |
| 4 | Insider transaction | Jul 7, 2026 | Jul 5, 2026 |
| 4 | Insider transaction | Jul 7, 2026 | Jul 5, 2026 |
| 4 | Insider transaction | Jul 7, 2026 | Jul 5, 2026 |
| 4 | Insider transaction | Jul 7, 2026 | Jul 5, 2026 |
| 4 | Insider transaction | Jul 7, 2026 | Jul 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 6, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jun 29, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jun 29, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jun 29, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jun 29, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jun 29, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jun 29, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jun 29, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jun 29, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jun 29, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jun 29, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 29, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 22, 2026 |
| 3 | Initial insider ownership | Jun 1, 2026 | Jun 1, 2026 |
| DEF 14A | Proxy statement | May 29, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 28, 2026 | May 28, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 27, 2026 | May 22, 2026 |
| 3 | Initial insider ownership | May 19, 2026 | May 16, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 19, 2026 | May 16, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 6, 2026 | — |
| EFFECT | Filing | May 4, 2026 | — |
| CORRESP | Letter to the SEC | May 1, 2026 | — |
| S-3/A | Filing | Apr 30, 2026 | — |
| 4 | Insider transaction | Apr 29, 2026 | Apr 24, 2026 |
| 3 | Initial insider ownership | Apr 29, 2026 | Apr 24, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 28, 2026 | Apr 24, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Apr 23, 2026 | Apr 22, 2026 |
| 10-K/A | Amended annual report | Apr 22, 2026 | Dec 31, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 17, 2026 | — |
| 8-K |
Current report
Shareholder vote results, Other events
|
Apr 14, 2026 | Apr 14, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 10, 2026 | Apr 7, 2026 |
| S-8 | Employee stock plan registration | Apr 9, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 6, 2026 | — |
| S-3 | Shelf registration | Apr 2, 2026 | — |
| 8-K |
Current report
Other events
|
Apr 1, 2026 | Mar 27, 2026 |
| 3 | Initial insider ownership | Mar 31, 2026 | Mar 27, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 31, 2026 | Mar 27, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 4, 2026 | — |
| D | Filing | Mar 4, 2026 | — |
| DEF 14A | Proxy statement | Mar 2, 2026 | Apr 14, 2026 |
| 3 | Initial insider ownership | Feb 27, 2026 | Feb 17, 2026 |
| 3 | Initial insider ownership | Feb 27, 2026 | Feb 17, 2026 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 24, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 24, 2026 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Feb 20, 2026 | — |
| PRE 14A | Preliminary proxy statement | Feb 20, 2026 | Apr 14, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 20, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 19, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
|
Feb 13, 2026 | Feb 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 2, 2026 | — |
| 8-K |
Current report
Listing notice
|
Jan 6, 2026 | Jan 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 5, 2026 | Dec 29, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 8, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 7, 2025 | — |
| 8-K |
Current report
Other events
|
Sep 25, 2025 | Sep 25, 2025 |
| S-8 | Employee stock plan registration | Aug 27, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 8, 2025 | — |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 7, 2025 | Aug 7, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 31, 2025 | — |
| 4 | Insider transaction | Jul 18, 2025 | Jul 16, 2025 |
| 4 | Insider transaction | Jul 18, 2025 | Jul 16, 2025 |
| 4 | Insider transaction | Jul 18, 2025 | Jul 16, 2025 |
| 4 | Insider transaction | Jul 18, 2025 | Jul 16, 2025 |
| 4 | Insider transaction | Jul 18, 2025 | Jul 16, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 11, 2025 | Jul 7, 2025 |
| 8-K |
Current report
Listing notice
|
Jun 27, 2025 | Jun 27, 2025 |
| 4/A | Filing | Jun 20, 2025 | Jun 5, 2025 |
| 4/A | Form 4 | Jun 20, 2025 | Jun 5, 2025 |
| 4/A | Filing | Jun 20, 2025 | Jun 4, 2025 |
| 4/A | Filing | Jun 20, 2025 | Jun 5, 2025 |
| 4/A | Filing | Jun 20, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 5, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 4, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 30, 2025 | May 28, 2025 |
| 424B5 | Prospectus supplement | May 30, 2025 | — |
| 424B5 | Prospectus supplement | May 28, 2025 | — |
| 8-K |
Current report
Other events
|
May 28, 2025 | May 28, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 8-K |
Current report
Other events
|
Apr 30, 2025 | Apr 30, 2025 |
| DEFA14A | Additional proxy material | Apr 22, 2025 | — |
| DEF 14A | Proxy statement | Apr 22, 2025 | Jun 4, 2025 |
| 424B5 | Prospectus supplement | Apr 9, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Apr 9, 2025 | Apr 9, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Feb 20, 2025 | Feb 20, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 30, 2025 | — |
| 8-K |
Current report
Other events
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 18, 2024 | Dec 13, 2024 |
| 4/A | Filing | Dec 9, 2024 | Dec 4, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 4, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 4, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 4, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 4, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 4, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 4 | Insider transaction | Nov 13, 2024 | Nov 12, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 12, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 7, 2024 | Nov 7, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 4, 2024 | — |
| 8-K |
Current report
Other events
|
Oct 22, 2024 | Oct 22, 2024 |
| 8-K |
Current report
Other events
|
Sep 10, 2024 | Sep 10, 2024 |
| 8-K |
Current report
Material agreement
|
Sep 3, 2024 | Aug 29, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 8, 2024 | Aug 8, 2024 |
| 4 | Insider transaction | Jul 24, 2024 | Jul 22, 2024 |
| 3 | Initial insider ownership | Jul 24, 2024 | Jul 22, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 24, 2024 | Jul 21, 2024 |
| 4 | Insider transaction | Jul 12, 2024 | Jul 12, 2024 |
| 3 | Initial insider ownership | Jul 12, 2024 | Jul 12, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 9, 2024 | Jul 9, 2024 |
| S-8 | Employee stock plan registration | Jul 2, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 12, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 12, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 12, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 12, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 12, 2024 | Jun 11, 2024 |
| 424B5 | Prospectus supplement | Jun 10, 2024 | — |
| EFFECT | Filing | May 31, 2024 | — |
| CORRESP | Letter to the SEC | May 29, 2024 | — |
| S-3/A | Pre-effective amendment no. 1 to form s-3 | May 24, 2024 | — |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
May 8, 2024 | May 8, 2024 |
| EFFECT | Filing | Apr 30, 2024 | — |
| 424B3 | Prospectus | Apr 30, 2024 | — |
| CORRESP | Letter to the SEC | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 23, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Mar 8, 2024 | Mar 4, 2024 |
| 4 | Insider transaction | Mar 6, 2024 | Mar 4, 2024 |
| 4 | Insider transaction | Mar 6, 2024 | Mar 4, 2024 |
| 4 | Insider transaction | Mar 6, 2024 | Mar 4, 2024 |
| 4 | Insider transaction | Mar 6, 2024 | Mar 4, 2024 |
| 4 | Insider transaction | Mar 6, 2024 | Mar 4, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IMUX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, United States
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1280776
- Former names
- VITAL THERAPIES INC (until Apr 10, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.